Felipe Couñago, Medical Director at GenesisCare Spain, about shared a post on LinkedIn:
“Our new paper in Advances, an ASTRO Journal in Radiation Oncology presents a global assessment of megavoltage radiotherapy infrastructure and projections through 2045.
The message is clear: Only 68% of patients who need radiotherapy worldwide currently have adequate access. By 2045, more than 20,000 additional machines will be required. Meanwhile, a large proportion of existing equipment is aging – even in high-income countries.
Radiotherapy is a cornerstone of cancer care. Without strategic planning, sustained investment, and global collaboration, the access gap will continue to widen. A special thank you to Reza Ghalehtaki for leading this ambitious global effort, and to all co-authors for the outstanding teamwork.
Equitable access to radiotherapy is not optional. It is a global responsibility.”
Title: Global Assessment of Megavoltage External Beam Radiotherapy Facilities: Current Status and Projections for 2030–2050
Authors: Fatemeh-sadat Tabatabaei, Amirali Azimi, Romina Abyaneh, Felipe Couñago, Filippo Alongi, Nina Sanford, Reza Ghalehtaki
Read the Full Article.
Other articles featuring Felipe Couñago on OncoDaily.